Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Amarin Corp Ads (NQ: AMRN)
6.800 USD  -0.030 (-0.44%)
Streaming Delayed Price  /  Updated: 2:15 PM EDT, Jun 3, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 3,673,192
Open 6.900
Bid (Size) 6.800 (93)
Ask (Size) 6.810 (81)
Prev. Close 6.830
Today's Range 6.755 - 6.930
52wk Range 3.950 - 26.12
Shares Outstanding 293,584,140
Dividend Yield N/A
Performance
YTD
-68.42%
-68.42%
1 Month
-10.76%
-10.76%
3 Month
-56.24%
-56.24%
6 Month
-68.56%
-68.56%
1 Year
-61.25%
-61.25%
Top News
More News
Amarin Plans to Increase VASCEPA® (icosapent ethyl) Promotion and Education
Significant Opportunity Seen as Patient Visits Resume to Emphasize VASCEPA as the First and Only Drug Approved for Its Current Cardiovascular Risk Reduction Indication Read More
from GlobeNewswire News Releases
Amarin Supports Trial to Investigate the Effects of VASCEPA® (icosapent ethyl) in the Treatment of COVID-19
from GlobeNewswire News Releases
More News
Read More
VASCEPA® (icosapent ethyl) Shows Significant Reduction in Coronary Revascularization, Including Coronary Stenting and Cardiac Bypass Surgery, in Prespecified and Post Hoc Analyses of Landmark REDUCE-I
from GlobeNewswire News Releases
Generic Threat To Amarin's Vascepa Overrides Positive Sentiment On Coronavirus Announcement
category Trading Ideas , Biotech , Ami Fadia , and 15 more.
from Benzinga
FDA Approves Generic Version of Amarin's Blockbuster Fish Oil Capsules
category AMRN , Market News , RDY , and 1 more.
from Motley Fool
8 Stocks Moving In Thursday's After-Hours Session
category A , News , PANW , and 12 more.
from Benzinga
Hikma receives FDA approval for generic of Amarin's Vascepa
category Pharma/Biotech , Stocks / Equities
from Blogs - TalkMarkets
1 Biotech Stock to Avoid at All Costs
category RDY , Market News , HIK , and 1 more.
from Motley Fool
IBB's Holdings Imply 17% Gain Potential
category ETFs
from ETF Channel
Is Amarin Stock a Buy?
category SRPT , HKMPF , Market News , and 3 more.
from Motley Fool
If You Invested $10,000 in Amarin's IPO, This Is How Much Money You'd Have Now
category INTU , Market News , AMRN
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.